MANCHESTER NEUROLOGICAL RESEARCH TRUST FUND

Registered charity 1073581 · accounts filings on the Charity Commission register

Research and scientific investigation into problems relating to causation, prevention, diagnosis or treatment of illness resulting from disease or disordered function of the nervous system. The focus of the Charity's work is on dementia.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£33k
Latest spending
£6k
Registered
1999
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the charity held unrestricted cash reserves of £240,316 at the end of the year, which the trustees acknowledge is in excess of what is needed. The trustees plan to spend these reserves in advance of the charity's objects to bring them down to a more realistic level. The charity has no employees and is managed by its board of trustees.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Public fundraising profile: JustGiving — Manchester Neurological Research Trust Fund (matched by registered charity number).

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Throughout England

Income and spending

Financial year endIncomeSpending
05/04/2025£33k£6k
05/04/2024£36k£992
05/04/2023£29k£12k
05/04/2022£31k£4k
05/04/2021£27k£22k

Common questions

Is MANCHESTER NEUROLOGICAL RESEARCH TRUST FUND financially healthy?

Per its FY2025 accounts: The accounts state that the charity held unrestricted cash reserves of £240,316 at the end of the year, which the trustees acknowledge is in excess of what is needed. The trustees plan to spend these reserves in advance of the charity's objects to bring them down to a more realistic level. The charity has no employees and is managed by its board of trustees. Its FY2025 accounts were independently examined.